Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

Nature Medicine

Volumn 13, Issue 11, 2007, Pages 1308-1315

  Weckmann, Markus ^a   Collison, Adam ^b   Simpson, Jodie L ^b,c   Kopp, Matthias V ^a   Wark, Peter A B ^b,c   Smyth, Mark J ^d   Yagita, Hideo ^e   Matthaei, Klaus I ^f   Hansbro, Nicole ^b   Whitehead, Bruce ^g   Gibson, Peter G ^b,c   Foster, Paul S ^b,f   Mattes, Joerg ^a,b,g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Biology and Environment   (Australia)

^g JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CHEMOKINE CCL20; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 13; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SMALL INTERFERING RNA; STAT6 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BONE MARROW CELL; BRONCHUS MUCOSA; CELL ACTIVATION; CELL HOMING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMETRY; DENDRITIC CELL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; SPUTUM; T LYMPHOCYTE; TH2 CELL; TRANSCRIPTION INITIATION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; CHEMOKINE CCL20; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RESPIRATORY HYPERSENSITIVITY; RNA INTERFERENCE; TH2 CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

MUS;

EID: 35948941870     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1660     Document Type: Article

References (50)

1. Bousquet, J., Bousquet, P.J., Godard, P. & Daures, J.P. The public health implications of asthma. Bull. World Health Organ. 83, 548-554 (2005).
2. Wills-Karp, M. Immunological basis of antigen-induced airways hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281 (1999).
3. Busse, W.W. Inflammation in asthma: the cornerstone of the disease and target of therapy. J. Allergy Clin. Immunol. 102, S17-S22 (1998).
4. Kay, A.B. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37 (2001).
5. Corry, D.B. et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183, 109-117 (1996).
6. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I. & Young, I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183, 195-201 (1996).
7. Temann, U.A., Geba, G.P., Rankin, J.A. & Flavell, R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188, 1307-1320 (1998).
8. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258-2261 (1998).
9. Grunig, G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263 (1998).
10. Robinson, D.S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304 (1992).
11. Bentley, A.M. et al. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8, 35-42 (1993).
12. Kroegel, C., Julius, P., Matthys, H., Virchow, J.C. Jr. & Luttmann, W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Eur. Respir. J. 9, 899-904 (1996).
13. Lambrecht, B.N., Salomon, B., Klatzmann, D. & Pauwels, R.A. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J. Immunol. 160, 4090-4097 (1998).
14. Lambrecht, B.N. et al. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106, 551-559 (2000).
15. + T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202, 1549-1561 (2005).
16. Kohl, J. et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116, 783-796 (2006).
17. Lambrecht, B.N. & Hammad, H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 3, 994-1003 (2003).
18. + T cell crosspriming in vivo. Immunity 24, 191-201 (2006).
19. Thorley, A.J., Goldstraw, P., Young, A. & Tetley, T.D. Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protein-3α)-induced dendritic cell migration. Am. J. Respir. Cell Mol. Biol. 32, 262-267 (2005).
20. Dieu-Nosjean, M.C. et al. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192, 705-718 (2000).
21. Reibman, J., Hsu, Y., Chen, L.C., Bleck, B. & Gordon, T. Airway epithelial cells release MIP-3α/CCL20 in response to cytokines and ambient particulate matter. Am. J. Respir. Cell Mol. Biol. 28, 648-654 (2003).
22. Zhang, Y. et al. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1α in mice. J. Natl. Cancer Inst. 96, 201-209 (2004).
23. Wiley, S.R. et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682 (1995).
24. Locksley, R.M., Killeen, N. & Lenardo, M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501 (2001).
25. Aggarwal, B.B., Shishodia, S., Ashikawa, K. & Bharti, A.C. The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Curr. Drug Targets Inflamm. Allergy 1, 327-341 (2002).
26. Robertson, N.M. et al. Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival. J. Immunol. 169, 5986-5996 (2002).
27. Zhang, X.R. et al. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ. 10, 203-210 (2003).
28. Daigle, I. & Simon, H.U. Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med. Wkly. 131, 231-237 (2001).
29. Takeda, K. et al. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195, 161-169 (2002).
30. Smyth, M.J. et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193, 661-670 (2001).
31. Takeda, K. et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7, 94-100 (2001).
32. Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosisinducing ligand in vivo. Nat. Med. 5, 157-163 (1999).
33. -/- mice. Nat. Immunol. 4, 255-260 (2003).
34. Begue, B. et al. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130, 1962-1974 (2006).
35. Mattes, J. et al. IL-13 induces airways hyperreactivity independently of the IL-4Rα chain in the allergic lung. J. Immunol. 167, 1683-1692 (2001).
36. Kuperman, D.A. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885-889 (2002).
37. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201, 981-991 (2005).
38. van Rijt, L.S. et al. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. J. Allergy Clin. Immunol. 114, 166-173 (2004).
39. Akbari, O. et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8, 1024-1032 (2002).
40. Lukacs, N.W., Prosser, D.M., Wiekowski, M., Lira, S.A. & Cook, D.N. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J. Exp. Med. 194, 551-555 (2001).
41. -/- mice is dependent upon altered pulmonary T lymphocyte activation. J. Immunol. 174, 2054-2060 (2005).
42. Mattes, J. et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195, 1433-1444 (2002).
43. Taube, C. et al. The role of IL-13 in established allergic airway disease. J. Immunol. 169, 6482-6489 (2002).
44. Walter, D.M. et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167, 4668-4675 (2001).
45. Venkayya, R. et al. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Respir. Cell Mol. Biol. 26, 202-208 (2002).
46. Yuan, B., Latek, R., Hossbach, M., Tuschl, T. & Lewitter, F. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32, W130-W134 (2004).
47. Kayagaki, N. et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163, 1906-1913 (1999).
48. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am. Rev. Respir. Dis. 136, 225-244 (1987).
49. Mattes, J. et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur. Respir. J. 13, 1391-1395 (1999).
50. Contoli, M. et al. Role of deficient type III interferon-λ production in asthma exacerbations. Nat. Med. 12, 1023-1026 (2006).